Trials / Terminated
TerminatedNCT02026960
RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate methods for AGS-003 production from surgical (stage I) and metastatic biopsy (stage II) Renal Cell Carcinoma (RCC) and a small subset of other GU cancers (expansion cohort) specimens using core needle biopsy in subjects with RCC or other GU cancers. Specifically, this study will evaluate the feasibility of RNA amplification from total tumor RNA isolated from tissues obtained by core needle tumor biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RNA extraction and amplification from biopsy specimens |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-03-01
- Completion
- 2017-09-07
- First posted
- 2014-01-03
- Last updated
- 2018-12-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02026960. Inclusion in this directory is not an endorsement.